NYSE: BFLY | Healthcare / Medical Devices & Instruments / USA |
1.09 | +0.0400 | +3.81% | Vol 1.29M | 1Y Perf -80.08% |
Oct 4th, 2023 16:00 DELAYED |
BID | 1.04 | ASK | 1.12 | ||
Open | 1.07 | Previous Close | 1.05 | ||
Pre-Market | - | After-Market | 1.09 | ||
- - | - -% |
Target Price | 6.00 | Analyst Rating | Strong Buy 1.00 | |
Potential % | 450.46 | Finscreener Ranking | — - | |
Insiders Trans % 3/6/12 mo. | -100/-67/-82 | Value Ranking | ★★★ 50.85 | |
Insiders Value % 3/6/12 mo. | -100/73/-7 | Growth Ranking | ★★★ 49.95 | |
Insiders Shares Cnt. % 3/6/12 mo. | -100/76/26 | Income Ranking | — - | |
Price Range Ratio 52W % | 0.94 | Earnings Rating | — | |
Market Cap | 225.23M | Earnings Date | 2nd Nov 2023 | |
Alpha | -0.05 | Standard Deviation | 0.22 | |
Beta | 1.87 |
Today's Price Range 1.021.10 | 52W Range 1.055.30 |
Summary:
Sell
Technical Indicators: | Neutral |
Moving Averages: | Strong Sell |
Performance | |||
---|---|---|---|
1 Week | -9.48% | ||
1 Month | -43.55% | ||
3 Months | -55.70% | ||
6 Months | -53.74% | ||
1 Year | -80.08% | ||
3 Years | -89.32% | ||
5 Years | - | ||
10 Years | - |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | - | |||
ROE last 12 Months | -37.80 | |||
ROA (5Y Avg) | - | |||
ROA last 12 Months | -29.36 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | -35.32 | |||
Return on invested Capital Q | -13.98 | |||
Return on invested Capital Y | -39.75 | |||
Assets Turnover | 0.00 | |||
Receivables Turnover | 2.30 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
-2.90 | ||||
1.30 | ||||
7.30 | ||||
- | ||||
-2.90 | ||||
-0.92 | ||||
1.30 | ||||
1.71 | ||||
211.39M | ||||
Forward PE | - | |||
PEG | - |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
6.10 | ||||
8.10 | ||||
0.08 | ||||
0.09 | ||||
-18 763.90 | ||||
Leverage Ratio | 1.30 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
51.00 | ||||
-204.50 | ||||
-198.10 | ||||
- | ||||
-63.28 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
54.41M | ||||
0.31 | ||||
- | ||||
- |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
- | ||||
- | ||||
- | ||||
Payout ratio | - |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q02 2023 | -0.17 | -0.14 | 17.65 |
Q01 2023 | -0.20 | -0.17 | 15.00 |
Q04 2022 | -0.21 | -0.17 | 19.05 |
Q03 2022 | -0.24 | -0.27 | -12.50 |
Q02 2022 | - | -0.18 | - |
Q01 2022 | - | -0.22 | - |
Q04 2021 | -0.30 | -0.08 | 73.33 |
Q03 2021 | -0.25 | -0.07 | 72.00 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
- | - | - | - |
- | - | - | - |
- | - | - | - |
- | - | - | - |
Next Report Date | 2nd Nov 2023 |
Estimated EPS Next Report | -0.14 |
Estimates Count | 2 |
EPS Growth Next 5 Years % | - |
Volume Overview | |
---|---|
Volume | 1.29M |
Shares Outstanding | 206.63K |
Shares Float | 152.13M |
Trades Count | 5.93K |
Dollar Volume | 1.38M |
Avg. Volume | 2.02M |
Avg. Weekly Volume | 1.51M |
Avg. Monthly Volume | 2.57M |
Avg. Quarterly Volume | 1.98M |
Butterfly Network Inc. Class A (NYSE: BFLY) stock closed at 1.05 per share at the end of the most recent trading day (a -6.25% change compared to the prior day closing price) with a volume of 1.27M shares and market capitalization of 225.23M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 260 people. Butterfly Network Inc. Class A CEO is Todd M. Fruchterman.
The one-year performance of Butterfly Network Inc. Class A stock is -80.08%, while year-to-date (YTD) performance is -57.32%. BFLY stock has a five-year performance of %. Its 52-week range is between 1.05 and 5.295, which gives BFLY stock a 52-week price range ratio of 0.94%
Butterfly Network Inc. Class A currently has a PE ratio of -2.90, a price-to-book (PB) ratio of 1.30, a price-to-sale (PS) ratio of 7.30, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -29.36%, a ROC of -35.32% and a ROE of -37.80%. The company’s profit margin is -63.28%, its EBITDA margin is -198.10%, and its revenue ttm is $54.41 Million , which makes it $0.31 revenue per share.
Of the last four earnings reports from Butterfly Network Inc. Class A, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.14 for the next earnings report. Butterfly Network Inc. Class A’s next earnings report date is 02nd Nov 2023.
The consensus rating of Wall Street analysts for Butterfly Network Inc. Class A is Strong Buy (1), with a target price of $6, which is +450.46% compared to the current price. The earnings rating for Butterfly Network Inc. Class A stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Butterfly Network Inc. Class A has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Butterfly Network Inc. Class A has a Sell technical analysis rating based on Technical Indicators (ADX : 29.15, ATR14 : 0.13, CCI20 : -91.36, Chaikin Money Flow : -0.33, MACD : -0.21, Money Flow Index : 44.06, ROC : -38.24, RSI : 24.06, STOCH (14,3) : 0.00, STOCH RSI : 0.00, UO : 31.39, Williams %R : -100.00), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Butterfly Network Inc. Class A in the last 12-months were: Andrei G. Stoica (Sold 57 427 shares of value $125 181 ), Darius Shahida (Sold 26 885 shares of value $63 446 ), Getz Heather C (Sold 65 577 shares of value $143 482 ), Heather C. Getz (Sold 64 536 shares of value $127 781 ), John David Martin (Sold 4 841 shares of value $11 667 ), John Martin (Sold 4 841 shares of value $11 684 ), Lawrence T. Weiss (Sold 52 296 shares of value $116 097 ), Stoica Andrei G (Sold 50 682 shares of value $110 846 ), Troy Quander (Sold 374 shares of value $980 ), Weiss Lawrence T (Sold 27 655 shares of value $60 509 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Strong Buy | Strong Buy | Strong Buy |
Butterfly Network Inc is an innovative digital health company. It is working towards democratizing medical imaging by making it accessible to everyone around the world and contribute to the aspiration of global health equity. The company has developed a groundbreaking single-probe, whole-body point-of-care ultrasound solution leveraging technology.
CEO: Todd M. Fruchterman
Telephone: +1 203 689-5650
Address: 530 Old Whitfield Street, Guilford 06437, CT, US
Number of employees: 260
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Copyright © 2023. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.
General partner of Finscreener is SLOVAKODATA, a.s.
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.